Rush Entpr Cl B (RUSHB) 23.75 $RUSHB Rush Enterprises

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Rush Entpr Cl B (RUSHB) 23.75 $RUSHB

Rush Enterprises Has Returned 29.1% Since SmarTrend Recommendation (RUSHB)
Comtex SmarTrend(R) - Mon Aug 29, 1:23PM CDT
SmarTrend identified an Uptrend for Rush Enterprises (NASDAQ:RUSHB) on March 21st, 2016 at $18.59. In approximately 5 months, Rush Enterprises has returned 29.10% as of today's recent price of $24.00.
RUSHB: 23.75 (-0.28)

Rush Enterprises Has Returned 33.7% Since SmarTrend Recommendation (RUSHB)
Comtex SmarTrend(R) - Fri Aug 12, 12:52AM CDT
SmarTrend identified an Uptrend for Rush Enterprises (NASDAQ:RUSHB) on March 21st, 2016 at $18.59. In approximately 5 months, Rush Enterprises has returned 33.73% as of today's recent price of $24.86.
RUSHB: 23.75 (-0.28)

25.3% Return Seen to Date on SmarTrend Rush Enterprises Call (RUSHB)
Comtex SmarTrend(R) - Thu Aug 04, 1:31PM CDT
SmarTrend identified an Uptrend for Rush Enterprises (NASDAQ:RUSHB) on March 21st, 2016 at $18.59. In approximately 5 months, Rush Enterprises has returned 25.28% as of today's recent price of $23.29.
RUSHB: 23.75 (-0.28)

Rush Enterprises Shares Up 25.0% Since SmarTrend's Buy Recommendation (RUSHB)
Comtex SmarTrend(R) - Thu Jul 28, 12:59AM CDT
SmarTrend identified an Uptrend for Rush Enterprises (NASDAQ:RUSHB) on March 21st, 2016 at $18.59. In approximately 4 months, Rush Enterprises has returned 24.96% as of today's recent price of $23.23.
RUSHB: 23.75 (-0.28)

Rush Enterprises posts 1Q profit
Automated Insights - Wed Apr 20, 6:03PM CDT
NEW BRAUNFELS, Texas (AP) _ Rush Enterprises Inc. (RUSHB) on Wednesday reported first-quarter profit of $2.4 million.
RUSHB: 23.75 (-0.28), RUSHA: 23.54 (+0.07)

Rush Enterprises beats 1Q profit forecasts
Automated Insights - Wed Apr 20, 6:01PM CDT
NEW BRAUNFELS, Texas (AP) _ Rush Enterprises Inc. (RUSHA) on Wednesday reported first-quarter earnings of $2.4 million.
RUSHB: 23.75 (-0.28), RUSHA: 23.54 (+0.07)

Rush Enterprises, Inc. Reports First Quarter 2016 Results
GlobeNewswire - Wed Apr 20, 5:55PM CDT
-- Revenues of $1.071 billion, $2.4 million net income
RUSHB: 23.75 (-0.28), RUSHA: 23.54 (+0.07)

Rush Enterprises, Inc. Conference Call Advisory for First Quarter 2016 Earnings Results
GlobeNewswire - Mon Apr 11, 9:37AM CDT
Rush Enterprises, Inc., (NASDAQ:RUSHA) (NASDAQ:RUSHB), which operates the largest network of commercial vehicle dealerships in North America will host a conference call to discuss earnings for the first quarter of 2016 on Thursday, April 21, 2016 at 10:00 a.m. Eastern/9:00 a.m. Central. Earnings will be reported after the close of market on Wednesday, April 20, 2016.
RUSHB: 23.75 (-0.28), RUSHA: 23.54 (+0.07)

Rush Enterprises, Inc. Reports Dealership Network Consolidation
GlobeNewswire - Wed Apr 06, 3:54PM CDT
Rush Enterprises, Inc. (NASDAQ:RUSHA) (NASDAQ:RUSHB), which operates the largest network of commercial vehicle dealerships in North America, today announced the implementation of a plan for consolidation of its Navistar Division dealership network that is intended to allow the Company to significantly reduce expenses while still providing efficient service to its customers in the affected areas of operation. The plan includes closing Rush Truck Centers in the following locations on May 1, 2016: Kankakee, Decatur, Ottawa, Mount Vernon and Grayslake, Illinois; Ontario, Oregon; Findlay, Ohio; and Statesville, North Carolina. Rush Truck Centers formerly located in Brazil, Indiana; and Helper, Utah, were closed in the first quarter of 2016. Additionally, as a result of acquisitions, the Company currently has two locations in each of Augusta and Tifton, Georgia, which will be consolidated into one location in Augusta and one location in Tifton on June 1, 2016. The Company also consolidated its Peterbilt location in Alice, Texas, into its newly constructed Corpus Christi, Texas, location in the first quarter of 2016. In total, the Company expects to close 13 Rush Truck Centers in the first half of 2016.
RUSHB: 23.75 (-0.28), RUSHA: 23.54 (+0.07)

Rush Enterprises misses 4Q profit forecasts
Automated Insights - Tue Feb 09, 6:30PM CST
NEW BRAUNFELS, Texas (AP) _ Rush Enterprises Inc. (RUSHA) on Tuesday reported fourth-quarter profit of $9.8 million.
RUSHB: 23.75 (-0.28), RUSHA: 23.54 (+0.07)

Rush Enterprises, Inc. Reports Fourth Quarter and Year-End 2015 Results
GlobeNewswire - Tue Feb 09, 5:13PM CST
-- Revenues of $5.0 billion, $66.1 million net income
RUSHB: 23.75 (-0.28), RUSHA: 23.54 (+0.07)

Rush Enterprises Shares Down 18.5% Since SmarTrend's Sell Call (RUSHB)
Comtex SmarTrend(R) - Mon Feb 01, 11:11AM CST
SmarTrend identified a Downtrend for Rush Enterprises (NASDAQ:RUSHB) on October 23rd, 2015 at $23.05. In approximately 3 months, Rush Enterprises has returned 18.51% as of today's recent price of $18.78.
RUSHB: 23.75 (-0.28)

Rush Enterprises Down 18.5% Since SmarTrend Downtrend Call (RUSHB)
Comtex SmarTrend(R) - Mon Feb 01, 10:59AM CST
SmarTrend identified a Downtrend for Rush Enterprises (NASDAQ:RUSHB) on October 23rd, 2015 at $23.05. In approximately 3 months, Rush Enterprises has returned 18.51% as of today's recent price of $18.78.
RUSHB: 23.75 (-0.28)

Rush Enterprises, Inc. Conference Call Advisory for Fourth Quarter and Year-End 2015 Earnings Results
GlobeNewswire - Thu Jan 28, 9:25AM CST
Rush Enterprises, Inc., (NASDAQ:RUSHA) (NASDAQ:RUSHB), which operates the largest network of commercial vehicle dealerships in North America will host a conference call to discuss earnings for the fourth quarter and year-end of 2015 on Wednesday, February 10, 2016 at 10:00 a.m. Eastern/9:00 a.m. Central. Earnings will be reported after the close of market on Tuesday, February 9, 2016.
RUSHB: 23.75 (-0.28), RUSHA: 23.54 (+0.07)

Shares of RUSHB Down 19.0% Since Downtrend Call on Shares
Comtex SmarTrend(R) - Mon Jan 25, 9:33AM CST
SmarTrend identified a Downtrend for Rush Enterprises (NASDAQ:RUSHB) on October 23rd, 2015 at $23.05. In approximately 3 months, Rush Enterprises has returned 18.98% as of today's recent price of $18.67.
RUSHB: 23.75 (-0.28)

BUYINS.NET: RUSHB SqueezeTrigger Price is $18.31. There is $1,537,718 That Short Sellers Still Need To Cover.
M2 - Thu Jan 21, 3:11AM CST
BUYINS.NET / www.squeezetrigger.com is monitoring Rush Enterprises Inc (NASDAQ:RUSHB) in real time and just received an alert that RUSHB is crossing above its primary SqueezeTrigger Price, the price that a short squeeze can start in any stock. There are 83300 shares that have been shorted at the volume weighted average SqueezeTrigger Price of $18.31. To access SqueezeTrigger Prices ahead of potential short squeezes beginning, visit http://www.squeezetrigger.com .
RUSHB: 23.75 (-0.28)

Downtrend Call Working As Rush Enterprises Stock Falls 15.5% (RUSHB)
Comtex SmarTrend(R) - Fri Jan 08, 9:59AM CST
SmarTrend identified a Downtrend for Rush Enterprises (NASDAQ:RUSHB) on October 23rd, 2015 at $23.05. In approximately 3 months, Rush Enterprises has returned 15.47% as of today's recent price of $19.48.
RUSHB: 23.75 (-0.28)

BUYINS.NET: CVV, ISRG, CCG, RUSHA, CRL, CIU Are Seasonally Ripe To Go Up In the Next Five Weeks
M2 - Fri Jan 08, 6:38AM CST
BUYINS.NET / www.squeezetrigger.com is monitoring the Seasonality of Canalaska Uranium Ltd (NASDAQ:CVV), Intuitive Surgical Inc (NASDAQ:ISRG), Campus Crest Communities Inc (NYSE:CCG), Rush Enterprises Inc (NASDAQ:RUSHA), CHARLES RIVER LABORATORIES INTERNATIONAL INC (NYSE:CRL), Ishares Barclays Intermediate Credit Bond Fund (NYSE:CIU) and each have a high seasonal probability to go Up in the next weeks. By identifying stocks that are poised to go up or down based on seasonal tendencies, traders can increase their odds of making money. SqueezeTrigger.com is able to analyze over 20 years of data in less than 1 second for any stock in the market and determine if the stock has a long or short seasonal bias, how many trading days the move is expected to last, the probability of that move and the percentage move the stock is expected to make based on the seasonal bias. The technology used to generate these predictions is available for a low monthly fee at:
ISRG: 688.37 (-1.32), CVV: 8.58 (+0.06), CRL: 84.42 (+0.82), RUSHB: 23.75 (-0.28), CIU: 111.29 (+0.02), RUSHA: 23.54 (+0.07), CCG: 7.00 (unch)

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Innovent's SINTBILO® Hits Primary Endpoint in Study

Updated Category News Views 119

Innovent's Latest Breakthrough with SINTBILO® One moment you're sipping coffee, the next you're staring at a clinical milestone. Innovent Biologics has shouted from the rooftops that their drug, SINTBILO® (tafolecimab injection), has wrapped up its Phase 3 CREDIT-5 study, snagging the primary endpoint with both hands. This isn't just any drug; it's marked as the first...

Continue Reading
Stavian Group Eyes AI-Driven Southeast Asia Growth

Updated Category News Views 50

AI and Infrastructure: A New Chapter for Southeast Asia What does Southeast Asia's future look like with AI steering the ship? Well, there's a fresh breeze of change blowing, and right at the heart of it stands Stavian Group. At the recently held inaugural Fortune SEA500 Summit in Ho Chi Minh City, this conglomerate threw its hat into the ring, painting a vision of growth...

Continue Reading
Intelligent Communication Forum Eyes Global Ecosystem Shift

Updated Category News Views 612

China's Grand Vision for Intelligent Communication You know what they say about big ideas—they start in the most bustling of places. And here we are in Wuxi, a city's pulse pounding with ambition, hosting the 2026 China International Intelligent Communication Forum. Picture it: From November 8th to 10th, movers, shakers, and visionaries are scribbling new blueprints for...

Continue Reading
Antengene’s AnTenGager-D2 Advances in Cancer Treatment

Updated Category News Views 56

Antengene's AnTenGager-D2 Offers Fresh Hope Alright, let's dig into the latest buzz from the 2026 Society for Immunotherapy of Cancer conference about Antengene's AnTenGager-D2 platform. If you're not into biotech lingo, buckle up, because this is a ride into the future of cancer treatments—where science fiction might soon become science fact. A Novel Approach to Tumor...

Continue Reading
D-Wave's Legal Trouble: Securities Fraud Suit Looms

Updated Category News Views 351

A Looming Legal Storm for D-Wave Investors Call it another day, another legal tangle in the investing world. This time, it's D-Wave Quantum Inc. (NASDAQ: QBTS) on the receiving end of a securities fraud class action lawsuit. Yeah, those fancy quantum computers they're pushing didn't predict this one coming. The legal arena is getting ready for a bout, and if you've got...

Continue Reading
CureGene's Evategrel Aims for Breakthrough in Stroke Care

Updated Category News Views 69

Revolutionizing Stroke Care: Enter Evategrel When it comes to strokes, time is money—and I'm telling you, this ain't an area where you can afford to twiddle your thumbs. The faster you can get that blood flowing again, the better the chance you've got of walking away with less damage. That's where CureGene's new investigational drug, Evategrel, comes in. Why Evategrel...

Continue Reading
Allergan Aesthetics Study Shows Rising Patient Satisfaction

Updated Category News Views 344

Enhanced Patient Satisfaction with Aesthetic Treatments Dive into the latest studies from Allergan Aesthetics—AbbVie's heavyweight in the beauty battleground. If you've got an ounce of optimism left in this market, their recent findings might just lift your spirits. Phase 4 studies, namely HARMONY IN DIVERSITY and HALO, are showing highly positive results among patients...

Continue Reading
Gildan's Crisis: Investors Face Losses Amid Lawsuit

Updated Category News Views 245

Gildan Investors, Brace Yourself Poor old Gildan Activewear finds itself in hot water again, with a class action lawsuit cropping up like an unexpected storm on farmers' day. Any traders remotely involved with NYSE:GIL should pay damn close attention, because with a December 14, 2026 deadline looming, it's crunch time. The Root of the Lawsuit The plot thickens here,...

Continue Reading
JNJ's Dual-Antigen Therapy Shows Promise in Prostate Cancer

Updated Category News Views 273

Exploring a New Front in Cancer Treatment Johnson & Johnson (NYSE: JNJ) just dropped a bombshell at the Society for Immunotherapy of Cancer (SITC) 2026 Annual Meeting, unveiling data that could reshape prostate cancer care. Their pioneering combo of pasritamig and JNJ-9401, a dual-antigen-targeted therapy, has the scientific community buzzing. Yeah, it's just Phase 1 baby...

Continue Reading
GlycoNex Eyes Japanese Market with Denosumab Biosimilar

Updated Category News Views 84

A Strategic Step into the Japanese Market Alright folks, there's a new kid aiming to shake things up in the biotech neighborhood, and it's GlycoNex with its denosumab biosimilar, SPD8. These guys just tossed their hat in the ring with a regulatory submission to Japan's Pharmaceuticals and Medical Devices Agency (PMDA). If the cosmic forces align, they might snag an...

Continue Reading

Top 5 Most Recently Viewed Articles

Equitage Ventures Launches $47.3M Fund for Senior Care Tech

Updated Category News Views 329

Equitage Ventures Launches Significant Investment Fund Equitage Ventures, an early-stage venture capital firm dedicated to AgeTech, has announced the successful final closing of a substantial $47.3 million investment fund. This fund is designed to provide critical capital, distribution resources, and strategic guidance to innovative entrepreneurs who aim to tackle the...

Continue Reading
Understanding Market Trends: Insights into Chevron Corp's Performance

Updated Category News Views 171

Chevron Corp Market Sentiment Analysis Chevron Corp (NYSE: CVX) has experienced a noteworthy decline in its short interest as a percentage of float, showing a 10.26% decrease since its previous report. Currently, there are approximately 14.02 million shares sold short, which accounts for 0.7% of all shares available for trading. Given the trading volume, it is estimated...

Continue Reading
Establishment of Blakely McCrory Hope Fund at Moody Gardens

Updated Category News Views 200

Introducing the Blakely McCrory Hope Fund Moody Gardens is proud to announce a special initiative to honor the memory of a young girl who captured the hearts of many: the Blakely McCrory Hope Fund. This fund has been established in loving memory of 8-year-old Blakely McCrory, who lost her life in a tragic flooding incident that occurred during the summer months....

Continue Reading
Star-Studded Table Read of 'It's a Wonderful Life' Event

Updated Category News Views 221

Exciting Holiday Table Read for a Worthy Cause The Ed Asner Family Center is pulling out all the stops this holiday season with an exciting virtual table read of the beloved classic, "It's a Wonderful Life." Scheduled for December 14 at 5 PM PST, this event promises to spread joy while supporting individuals and families with special needs. Star-Studded Cast Comes...

Continue Reading
Transforming $100 Into Over $1700 with Monolithic Power Systems

Updated Category News Views 145

Understanding the Growth of Monolithic Power Systems Monolithic Power Systems (NASDAQ: MPWR) has showcased impressive financial performance over the past decade, outperforming many market benchmarks. With an impressive annualized growth rate of 19.88%, it has attracted the attention of savvy investors. The Power of Compounded Returns Imagine investing $100 in MPWR stock...

Continue Reading